Delivery Order SPE2DB20D3505-SPE2DB23FU2A7
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,008.00 firm fixed-price delivery order is for the supply of 50-count boxes of Freestyle Lite test strips. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $2,194.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Freestyle Lite Test Strips, a critical medical supply for the Department of Defense (DoD) and other government healthcare programs. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide Freestyle Lite test strips. The $1,463.04 firm-fixed-price delivery order has a completion date of January 27, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for delivering a wide range of pharmaceutical products and medical supplies to support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,513.82 firm fixed-price delivery order is for the supply of 4,568,235,549 units of Freestyle Lite Test Strips, a medical product used for diabetes management. The contract has a period of performance through May 14, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,668.81 Firm Fixed Price delivery order contract covers the provision of 4563153510 Freestyle Lite Test Strips, and has an ultimate completion date of December 21, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,004.52, is a Firm Fixed Price Delivery Order for the supply of Freestyle Lite Test Strips. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,047.24, is a delivery order for the supply of Freestyle Lite Test Strips, a medical product used for diabetes management. The contract has a period of performance through March 2025 and is a firm fixed-price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,046.29 firm fixed-price delivery order is for the supply of Freestyle Lite Test Strips, a medical product used for glucose monitoring. The contract has an ultimate completion date of May 4, 2023. Amerisourcebergen is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,536.59, is for the delivery of Freestyle Lite Test Strips, a medical product used for diabetes management. The contract is a Delivery Order and has a Firm Fixed Price pricing type, with an ultimate completion date of April 26, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This federal contract award, valued at $24,318.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Freestyle Lite Test Strips, a medical product used for diabetes management. The contract has an ultimate completion date of December 27, 2023 and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB23FU2A7Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,650.78, is for the delivery of Freestyle Lite Test Strips to support military and veterans' healthcare programs. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 6/1/23 |